ABTC Protocol Status

As of December 12, 2017 at 3:19 P.M.

Protocol Number Protocol Title Newly or Recurrent Current Phase Protocol Arm/Group Slots Available Slots on Hold Total number of patients enrolled to date Current Status Wait List Est. Next Cohort Start Date
1202 MK-1775 Newly I Combination Dose Cohort 0

0

Arm 1: 15

Arm 2: 24

Combination Dose: 12

CLOSED

NA NA
1202 MK-1775 Recurrent I Intratumoral Drug Distribution 0 0

12

(+1replaced)

CLOSED NA NA
1301 MLN-0128 Recurrent 0

   Part 2   

Groups A and B

14 2(DF,SF)

Part 1-Cohort A: 11

Part 1: Cohort B: 5

(+1replaced)

Part 2: 4

OPEN

NA

NA
1302 LAPATINIB Recurrent 0 Group A 9 2(SK) 9

OPEN

NA NA
1403 Il-7 Newly NA

Group A

(Dex≤0.75mg/day)

30 0 0

CLOSED 

NA Early 2018. Amendment underway
1403 Il-7 Newly NA

Group B

(Dex<0.75mg/day)

20 0 0 CLOSED NA Early 2018. Amendment underway
1501 Checkpoint Inhibitors Recurrent I

PartA LAG-3 Mono

PartA CD137 Mono

PartB LAG-3 Combo

0 0

20

(+1replaced)

TEMP CLOSED 

6 (2CC,UA,SK,PT, UP)

Undetermined. Protocol amendment underway
1602 PT2385 Recurrent II Stage 1 13

1(WF)

10 OPEN NA NA